Multiple candidate gene analysis identifies α-synuclein as a susceptibility gene for sporadic Parkinson's disease

Human Molecular Genetics

Volumn 15, Issue 7, 2006, Pages 1151-1158

  Mizuta, Ikuko ^a   Satake, Wataru ^a   Nakabayashi, Yuko ^a,b   Ito, Chiyomi ^a,b   Suzuki, Satoko ^a,b   Momose, Yoshio ^a,i   Nagai, Yoshitaka ^a   Oka, Akira ^c   Inoko, Hidetoshi ^c   Fukae, Jiro ^d   Saito, Yuko ^e,f   Sawabe, Motoji ^e   Murayama, Shigeo ^f   Yamamoto, Mitsutoshi ^g   Hattori, Nobutaka ^d   Murata, Miho ^h   Toda, Tatsushi ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Tokyo Metropolitan Institute of Gerontology   (Japan)

^f TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^g KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^h NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; HUMAN TISSUE; LEWY BODY; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; CASE-CONTROL STUDIES; CEREBRAL CORTEX; FEMALE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33645111633     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddl030     Document Type: Article

References (44)

1. Rascol, O., Payoux, P., Ory, F., Ferreira, J.J., Brefel-Courbon, C. and Montastruc, J.-L. (2003) Limitations of current Parkinson's disease therapy. Ann. Neurol., 53 (Suppl. 3), S3-S12.
2. Warner, T.T. and Schapira, A.H. (2003) Genetic and environmental factors in the cause of Parkinson's disease. Ann. Neurol., 53 (Suppl. 3), S16-S23.
3. Elbaz, A., Grigoletto, F., Baldereschi, M., Breteler, M.M., Manubens-Bertran, J.M., Lopez-Pousa, S., Dartigues, J.F., Alperovitch, A., Tzourio, C., Rocca, W.A. et al. (1999) Familial aggregation of Parkinson's disease: A population-based case-control study in Europe. Neurology, 52, 1876-1882.
4. Sveinbjörnsdóttir, S., Hicks, A.A., Jónsson, T., Pétursson, H., Gugmundsson, G., Frigge, M.L., Kong, A., Gulcher, J.R. and Stefánsson, K. (2000) Familial aggregation of Parkinson's disease in Iceland. N. Engl. J. Med., 343, 1765-1770.
5. Piccini, P., Burn, D.J., Ceravolo, R., Maraganore, D. and Brooks, D.J. (1999) The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins. Ann. Neurol., 45, 577-582.
6. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045-2047.
7. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605-608.
8. Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M.J., Jonnalagada, S., Chernova, T. et al. (1998) The ubiquitin pathway in Parkinson's disease. Nature, 395, 451-452.
9. Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M.K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 304, 1158-1160.
10. Bonifati, V., Rizzu, P., van Baren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., Dekker, M.C.J., Squitieri, F., Ibanez, P., Joosse, M. et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science, 299, 256-259.
11. Paisán-Ruiz, C., Jain, S., Evans, E.W., Gilks, W.P., Simón, J., van der Brug, M., Lopez de Munain, A., Aparicio, S., Gil, A.M., Khan, N. et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron, 44, 595-600.
12. Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R.J., Calne, D.B. et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron, 44, 601-607.
13. Le, W.-D., Xu, P., Jankovic, J., Jiang, H., Appel, S.H., Smith, R.G. and Vassilatis, D.K. (2003) Mutations in NR4A2 associated with familial Parkinson disease. Nat. Genet., 33, 85-89.
14. DeStefano, A.L., Golbe, L.I., Mark, M.H., Lazzarini, A.M., Maher, N.E., Saint-Hilaire, M., Feldman, R.G., Guttman, M., Watts, R.L., Suchowersky, O. et al. (2001) Genome-wide scan for Parkinson's disease: The GenePD Study. Neurology, 57, 1124-1126.
15. Hicks, A.A., Pétursson, H., Jóhnson, T., Stefánsson, H., Jóhannsdóttir, H.S., Sainz, J., Frigge, M.L., Kong, A., Gulcher, J.R., Stefánsson, K. et al. (2002) A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann. Neurol., 52, 549-555.
16. Pankratz, N., Nichols, W.C., Uniacke, S.K., Halter, C., Rudolph, A., Shults, C., Conneally, P.M., Foroud, T. and the Parkinson Study Group (2002) Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. Am. J. Hum. Genet., 71, 124-135.
17. Scott, W.K., Nance, M.A., Watts, R.L., Hubble, J.P., Koller, W.C., Lyons, K., Pahwa, R., Stern, M.B., Colcher, A., Hiner, B.C. et al. (2001) Complete genomic screen in Parkinson disease: Evidence for multiple genes. JAMA, 286, 2239-2244.
18. Martin, E.R., Scott, W.K., Nance, M.A., Watts, R.L., Hubble, J.P., Koller, W.C., Lyons, K., Pahwa, R., Stern, M.B., Colcher, A. et al. (2001) Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA, 286, 2245-2250.
19. van der Walt, J.M., Noureddine, M.A., Kittappa, R., Hauser, M.A., Scott, W.K., McKay, R., Zhang, F., Stajich, J.M., Fujiwara, K., Scott, B.L. et al. (2004) Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. Am. J. Hum. Genet., 74, 1121-1127.
20. Spillantini, M.G., Schmidt, M.L., Lee, V.M.-Y., Trojanowski, J.Q., Jakes, R. and Goedert, M. (1997) α-synuclein in Lewy bodies. Nature, 388, 839-840.
21. Goedert, M. (2001) Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci., 2, 492-501.
22. Schildkraut, J.M. (1998) Examining complex genetic interactions. In Haines, J.L. and Pericak-Vance, M.A. (eds), Approaches to Gene Mapping in Complex Human Diseases. Wiley-Liss, NY, pp. 379-410.
23. Mueller, J.C., Fuchs, J., Hofer, A., Zimprich, A., Lichtner, P., Illig, T., Berg, D., Wüllner, U., Meitinger, T. and Gasser, T. (2005) Multiple regions of α-synuclein are associated with Parkinson's disease. Ann. Neurol., 57, 535-541.
24. Pals, P., Lincoln, S., Manning, J., Heckman, M., Skipper, L., Hulihan, M., Van den Broeck, M., De Pooter, T., Cras, P., Crook, J. et al. (2004) α-Synuclein promoter confers susceptibility to Parkinson's disease. Ann. Neurol., 56, 591-595.
25. Maroteaux, L., Campanelli, J.T. and Scheller, R.H. (1988) Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci., 8, 2804-2815.
26. Eriksen, J.L., Dawson, T.M., Dickson, D.W. and Petrucelli, L. (2003) Caught in the act: α-synuclein is the culprit in Parkinson's disease. Neuron, 40, 453-456.
27. Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J.T., Schöls, L. and Riess, O. (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet., 18, 106-108.
28. Zarranz, J.J., Alegre, J., Gómez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B. et al. (2004) The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol., 55, 164-173.
29. Nagar, S., Juyal, R.C., Chaudhary, S., Behari, M., Gupta, M., Rao, S.N. and Thelma, B.K. (2001) Mutations in the α-synuclein gene in Parkinson's disease among Indians. Acta Neurol. Scand., 103, 120-122.
30. Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R. et al. (2003) α-Synuclein locus triplication causes Parkinson's disease. Science, 302, 841.
31. Miller, D.W., Hague, S.M., Clarimon, J., Baptista, M., Gwinn-Hardy, K., Cookson, M.R. and Singleton, A.B. (2004) α-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology, 62, 1835-1838.
32. Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M. et al. (2004) α-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet, 364, 1167-1169.
33. Ibáñez, P., Bonnet, A.-M., Débarges, B., Lohmann, E., Tison, F., Pollak, P., Agid, Y., Dürr, A., Brice, A. and French Parkinson's Disease Genetics Study Group (2004) Causal relation between α-synuclein gene duplication and familial Parkinson's disease. Lancet, 364, 1169-1171.
34. Xia, Y., Rohan de Silva, H.A., Rosi, B.L., Yamaoka, L.H., Rimmler, J.B., Pericak-Vance, M.A., Roses, A.D., Chen, X., Masliah, E., DeTeresa, R. et al. (1996) Genetic studies in Alzheimer's disease with an NACP/ α-synuclein polymorphism. Ann. Neurol., 40, 207-215.
35. Farrer, M., Maraganore, D.M., Lockhart, P., Singleton, A., Lesnick, T.G., de Andrade, M., West, A., de Silva, R., Hardy, J. and Hernandez, D. (2001) α-synuclein gene haplotypes are associated with Parkinson's disease. Hum. Mol. Genet., 10, 1847-1851.
36. Parsian, A., Racette, B., Zhang, Z.H., Chakraverty, S., Rundle, M., Goate, A. and Perlmutter, J.S. (1998) Mutation, sequence analysis, and association studies of α-synuclein in Parkinson's disease. Neurology, 51, 1757-1759.
37. Tan, E.-K., Tan, C., Shen, H., Chai, A., Lum, S.-Y., Teoh, M.-L., Yih, Y., Wong, M.-C. and Zhao, Y. (2003) Alpha synuclein promoter and risk of Parkinson's disease: Microsatellite and allelic size variability. Neurosci. Lett., 336, 70-72.
38. Jobling, M.A., Hurles, M. and Tyler-Smith, C. (2004) Human Evolutionary Genetics. Garland Science, NY, pp. 45-86.
39. Altshuler, D., Brooks, L.D., Chakravarti, A., Collins, F.S., Daly, M.J., Donnelly, P. and the International HapMap Consortium (2005) A haplotype map of the human genome. Nature, 437, 1299-1320.
40. Murray, I.V.J., Giasson, B.I., Quinn, S.M., Koppaka, V., Axelsen, P.H., Ischiropoulos, H., Trojanowski, J.Q. and Lee, V.M.-Y. (2003) Role of α-synuclein carboxy-terminus on fibril formation in vitro. Biochemistry, 42, 8530-8540.
41. Serpell, L.C., Berriman, J., Jakes, R., Goedert, M. and Crowther, R.A. (2000) Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation. Proc. Natl Acad. Sci. USA, 97, 4897-4902.
42. Bower, J.H., Maraganore, D.M., McDonnell, S.K. and Rocca, W.A. (1999) Incidence and distribution of Parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology, 52, 1214-1220.
43. Haga, H., Yamada, R., Ohnishi, Y., Nakamura, Y. and Tanaka, T. (2002) Gene-based SNP discovery as part of the Japanese Millennium Genome Project: Identification of 190 562 genetic variations in the human genome. J. Hum. Genet., 47, 605-610.
44. McKeith, I.G., Dickson, D.W., Lowe, J., Emre, M., O'Brien, J.T., Feldman, H., Cummings, J., Duda, J.E., Lippa, C., Perry, E.K. et al. (2005) Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology, 65, 1863-1872.